首页|2020~2023年某院利拉鲁肽注射液用药分析

2020~2023年某院利拉鲁肽注射液用药分析

扫码查看
目的 调查分析某院利拉鲁肽注射液的住院医嘱,对其用药安全性及合理性进行探讨,旨在提高该药在某院的合理使用水平。方法 通过合理用药软件系统抽取 1 099 份使用过利拉鲁肽注射液的住院病例,结合电子病例系统对其用药情况进行统计分析。结果 使用利拉鲁肽注射液的患者以 60~79 岁的老年人为主,主要集中在合并肥胖、心血管疾病高危因素、动脉粥样硬化性心血管疾病等人群,使用较多的科室是内分泌科以及心脏病科,住院医嘱合格率为 77。07%,不良反应发生率为 4。19%。结论 某院在利拉鲁肽注射液的使用方面还存在较多问题,需要综合评估其安全性及有效性,以保障患者用药合理性与经济性。
Drug analysis of liraglutide injection in a hospital from 2020 to 2023
Objective To investigate and analyze the medical advice of liraglutide injection in a hospital,and explore its safety and rationality,aiming to improve the reasonable use of this drug in the hospital.Methods 1 099 inpatient cases using liraglutide injection were extracted from the rational drug use software system,and their drug use was statistically analyzed in combination with the electronic case system.Results Most of the patients who used liraglutide injection are aged 60 to 79 years old,mainly concentrated in people with obesity,high-risk factors of cardiovascular disease,atherosclerotic cardiovascular disease and so on.The departments that used it most are endocrinology department and cardiology department.The pass rate of inpatient medical orders is 77.07%,and the incidence of adverse reactions is 4.19%.Conclusion There are still many problems in the use of liraglutide injection in this hospital,and its safety and effectiveness need to be comprehensively evaluated to ensure the rationality and economy of patients'medication.

Liraglutide injectionDrug analysisRational medication

高海玲、周晨、顾琰华

展开 >

南通市海门区中医院,江苏南通 226100

利拉鲁肽注射液 用药分析 合理用药

南通市海门区科学计划

2021SF30

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(6)